FindTrial
Sign In

Retrospective review of clinical ultrasound contrast agents adverse reactions and treatment

Retrospective review of clinical ultrasound contrast agents adverse reactions and treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048847
Enrollment
Unknown
Registered
2021-07-18
Start date
2019-10-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tumor

Interventions

Gold Standard:ACR Manual on Contrast Media(V10.3)
Index test:NA

Sponsors

the First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who have undergone contrast-enhanced ultrasound examination and have different degrees of adverse reactions to ultrasound contrast agents.

Exclusion criteria

Exclusion criteria: Patients with severe lack of medical records.

Design outcomes

Primary

MeasureTime frame
adverse reactions;—

Countries

China

Contacts

Public ContactGuo Yanli

the First Affiliated Hospital of Army Medical University

guoyanli71@aliyun.com+86 13608351873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026